CS logo
small CS logo
Terveystalo Oulu

Oulu, Finland
Sairaalakeskus Oulussa

About Terveystalo Oulu


"Tule turvallisesti paikan päälle tai asioi etänä. Varaa aika verkkosivuiltamme tai asiakaspalvelun kautta numerosta 030 6000. Ajanvaraus on auki vuorokauden ympäri. Koko Suomen kattavaa toimipaikkaverkostoa täydentävät ympäri vuorokauden saatavilla olevat digitaaliset etäpalvelut. Lääkäri-chat päivystää ilman ajanvarausta 24/7. Voit myös varata ajan video- tai puhelinvastaanotolle valitsemallesi asiantuntijalle. Nopeasti hyvään hoitoon!"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Boehringer Ingelheim
3
Bayer
2
Biohit Oyj
2
Pfizer
2
Hoffmann-La Roche
1
Total Rows: 5

Clinical Trials at Terveystalo Oulu


During the past decade, Terveystalo Oulu conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 6 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100001100002200000044001100Started TrialsCompleted Trails20152016201720182019202020210246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes
2010-11-11
2018-08-21
Completed
6,103
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Linagliptin as Add on to Basal Insulin in the Elderly
2014-09-23
2017-04-25
Completed
302
The Efficacy of L-cysteine in Prevention of Cluster Headache
2013-12-17
2020-10-14
Completed
60
The Efficacy of L-cysteine in Prevention of Headache Attacks in Migraine Patients
2013-12-17
2020-09-07
Completed
200
Empagliflozin as Adjunctive to InSulin thErapy Over 52 Weeks in Patients With Type 1 Diabetes Mellitus (EASE-2)
2015-06-30
2017-10-23
Completed
730
A Double-blind Study to Investigate Efficacy, Safety and Tolerability of BAY1142524 in Patients With Type II Diabetes and a Clinical Diagnosis of Diabetic Kidney Disease
2018-02-02
2019-10-10
Completed
152

Rows per page:

1–10 of 10

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Terveystalo Oulu" #1 sponsor was "Boehringer Ingelheim" with 3 trials, followed by "Bayer" with 2 trials sponsored, "Biohit Oyj" with 2 trials sponsored, "Pfizer" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Terveystalo Oulu" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator and "The Finnish Funding Agency for Technology and Innovation (TEKES)" with 2 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBoehringer Ingelheim: 3Boehringer Ingelheim: 3Bayer: 2Bayer: 2Biohit Oyj: 2Biohit Oyj: 2Pfizer: 2Pfizer: 2Hoffmann-La Roche: 1Hoffmann-La Roche: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 3Eli Lilly and Company: 3The Finnish FundingAgency for Technologyand Innovation (TEKES):2The Finnish FundingAgency for Technologyand Innovation (TEKES):2

Clinical Trials Conditions at Terveystalo Oulu


According to Clinical.Site data, the most researched conditions in "Terveystalo Oulu" are "Cardiovascular Disease" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Chronic Kidney Disease" (1 trials), "Cluster Headache" (1 trials) and "Diabetes Mellitus, Type 1" (1 trials). Many other conditions were trialed in "Terveystalo Oulu" in a lesser frequency.

Clinical Trials Intervention Types at Terveystalo Oulu


Most popular intervention types in "Terveystalo Oulu" are "Drug" (10 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Acetium" (2 trials), "bococizumab (PF-04950615)" (2 trials), "linagliptin" (2 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Terveystalo Oulu


The vast majority of trials in "Terveystalo Oulu" are 10 trials for "All" genders.

Clinical Trials Status at Terveystalo Oulu


Currently, there are NaN active trials in "Terveystalo Oulu". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Terveystalo Oulu, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Terveystalo Oulu, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 5Phase 3: 5Not Applicable: 2Not Applicable: 2Phase 2: 2Phase 2: 2Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 7Completed: 7Terminated: 2Terminated: 2Recruiting: 1Recruiting: 1